Peri-Procedural Infarction: More Frequent than and Not as Innocent as We Thought

Almost 30% of all patients experience some degree of myocardial injury after elective angioplasty, a statistic associated to an increase in cardiovascular events at 30 days and 1 year, according to this study recently published in Eur Heart J.

infarto peri-procedimientoThe study only included consecutive patients who underwent elective angioplasty with a negative troponin level at admission. The primary endpoint was defined as a composite of peri-procedural infarction (type 4a infarction), stent thrombosis (type 4b), and myocardial injury according to the third universal definition of infarction.

Multivariable analysis was performed to identify independent predictors of infarction and myocardial injury, and their relation to 30-day and 1-year events.


Read also: ACC 2018 | SECURE-PCI: High Dose of Statins pior PCI Could Help.


Among 1390 patients who underwent elective angioplasty, the primary endpoint was observed in 28.7% of cases, including 7.0% of type 4a infarction, 0.14% of type 4b infarction, and 21.6% of myocardial injury.

Independent risk factors were left main disease, total stent length >30 mm, multiple stenting, chronic kidney disease (estimated glomerular filtration rate <60 mL/min), and age >75 years old.

At 30 days, patients with peri-procedural infarction or myocardial injury had a higher rate of cardiovascular events (5.5% vs. 1.2%; p < 0.001), which was mainly driven by ischemic events (3.2% vs. 0.6%; p < 0.0001).


Read also: Surgery Seems Superior to Angioplasty in Young Patients.


At 1 year, the risk of events remained higher for patients with peri-procedural infarction or myocardial injury (p = 0.004).

Conclusion

Peri-procedural infarction and myocardial injury are frequent complications of elective angioplasty and are associated with an increase in cardiovascular events at 30 days and 1 year.

Original title: Periprocedural Myocardial Infarction and Injury in Elective Coronary Stenting.

Reference: Michel Zeitouni et al. Eur Heart J. 2018 Apr 1;39(13):1100-1109.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...